One biopsy specimen from 2 nd -3 rd duodenal portion was embedded in an optimal cutting temperature compound (OCT-Tissue-Tek, Sakura, Finetek, Netherland) and immediately frozen in liquid nitrogen. Frozen biopsy samples were stored at -80ºC until used. Six sections (5 µm) from each patient were examined by double immunofluorescence for intestinal deposits of anti-tTG2 IgA antibodies. The staining protocol was performed in a humid chamber at room temperature. The sections were first incubated with a mouse monoclonal antibody against tTG2 (clone CUB7402) (dilution 1:200, 15 minutes; Abcam, Cambridge, UK). The sections were washed in PBS and incubated with a secondary antibody anti-mouse-Alexa 594 conjugated (red) (1:200, 15 minutes) from Invitrogen (Paisley, UK). Slides were then washed again and stained with FITC-labelled Rabbit polyclonal antibody to human IgA (green) (1:40, 30 minutes). Samples from IgA deficient patients were incubated with polycolonal rabbit anti-human IgG under the same conditions. Both antibodies were from Dako (Denmark). Finally, the sections were washed twice in PBS and mounted with a fluorescent mounting medium (Dako, Denmark). The colocalization images of IgA mucosal deposits and TG2, which appeared in yellow/orange, were analysed with a confocal microscope (SP2, Leica, Germany). The evaluation of anti-TG2 IgA deposits was performed considering the pattern and the intensity of the staining as described 1 . Positive deposits were considered to be of either low (+) or high (++) intensity. In our previous study, 2 of the 10 healthy controls (20%; CI, 5.6% to 50%) with negative HLA-DQ2/8 haplotypes showed low intensity positive deposits. In other previous studies, non-coeliac control subjects also presented positive mucosal deposits in 12 to 20% of cases (see reference 1).
HLA genotyping
Genomic DNA from whole blood was purified using the commercial Qiamp DNA Blood Mini kit (Qiagen, Düsseldorf, Germany). A commercial reverse hybridization kit for the detection of CD heterodimers HLA-DQ2.5 (A1*0501/*0505, B1*0201/*0202) and HLA-DQ8 (A1*0301, B1*0302) was used (GenID, GMBH, Strasburg, Germany). HLA-DQ2.5 haplotype was present in 24% of healthy controls and 90% of CD patients in our geographical area. 2 In the present study, positive coeliac genetics indicated the presence of HLA-DQ2.5 and/or HLA-DQ8. Figure S1 . Evolution of the intraepithelial lymphocyte count (IEL count per 100 epithelial nuclei) in patients with clinical and histological remission/response after a GFD. Figure S2 . ROC curve for the accuracy of the scoring system at identifying patients with low-grade coeliac enteropathy after excluding patients with positive serum anti-tTG2. AUC: area under the curve, ROC: receiver operating characteristic.
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